Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
11 Total results for product and free and sample content found
Datamonitor Healthcare
By Ljlal Syed, Mark Lansdell and David Abramson 19 Aug 2017
This report examines the extent to which order of market entry influences the prospects of achieving a satisfactory return on investment for companies developing branded generic
Topic Deal trends
Pharmaprojects
By Ian Lloyd 22 Mar 2017
Welcome to Pharmaprojects' 2017 review of trends in pharmaceutical R&D.
Medtech Insight
By Tina Tan 02 Dec 2016
As the end of the year approaches, medtech venture financing activity looks to have picked up in November to be on par with the previous year's level – but not enough to bridge the gap in annual performances.
Topic Deal trends
RxScorecard
28 Nov 2016
When it comes to value frameworks, one thing is certain, they’re here to stay.
Topic Reimbursement Deal trends
Medtrack
By Steven Muntner 20 Oct 2016
Royalty payments are an essential component of most pharmaceutical deals. Along with upfront payments and milestones, companies are rewarded for surpassing certain developmental hurdles.
Topic Deal trends Medtech
Scrip
26 Sep 2016
Seasoned generics and intellectual property expert Richard Saynor went from poacher to game keeper
Topic Deal trends
Meddevicetracker
By Pharma Intelligence 23 Aug 2016
EuroPCR is the world leading course in interventional cardiovascular medicine - catch up on the 2016 event with our detailed coverage.
Topic Deal trends
Meddevicetracker
By Pharma Intelligence 20 May 2016
This report highlights Meddevicetracker’s coverage on the recent EuroPCR event and shows you how information is easier to find and the additional benefits from the data and analysis provided
Topic Deal trends Medtech
Datamonitor Healthcare
By Tijana Ignjatovic 23 Nov 2015
Despite the challenges with the implementation of managed entry agreements, the debate involving these complex market access routes is not abating.
Topic Deal trends
No Records Found
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Report store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
